Three plaintiffs suing Boston Scientific in Philadelphia over allegedly defective pelvic mesh have agreed to litigate their cases elsewhere in light of the latest jurisdictional pronouncement from the U.S. Supreme Court.

Last month, Boston Scientific had asked the court to remove any cases pending against it in the Philadelphia Court of Common Pleas, citing the Supreme Court's recent game-changing decisions in Bristol-Myers Squibb v. Superior Court of California and BNSF Railway v. Tyrrell. But, according to a lead attorney in the litigation, the parties have agreed to litigate the cases in either Massachusetts, where Boston Scientific has its principal place of business, or Delaware.

“We agreed with Boston Scientific to go forward and litigate the case in a different court,” Kline & Specter attorney Shanin Specter said.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT